Josh Hamermesh | Chief Business Officer |
Julian Adams | CEO |
Michele Korfin | COO and Chief Commercial Officer |
Shai Lankry | Chief Commercial Officer |
Ronit Simantov | Chief Medical Officer |
Tracey Lodie | Chief Scientific Officer |
Ted Tenthoff | Piper Sandler |
Jonathan Miller | Evercore ISI |
Jason Butler | JMP Securities |
Vernon Bernadino | H.C. Wainwright |
Gregory Renza | RBC Capital Markets |
Thank you, Lodie, and good morning, everyone. Welcome to today’s call, during which we will provide an update on the Company and review our financial results for the first quarter of 2021. Earlier this morning, we issued a press release summarizing our financial results and progress across the Company, which is available on our website at www.gamida-cell.com.
Here with me on our call today are Julian Adams, Chief Executive Officer; Michele Korfin, our Chief Operating Officer and Chief Commercial Officer; and Shai Lankry, Chief Commercial Officer. Ronit Simantov, Chief Medical Officer; Tracey Lodie, our Chief Scientific Officer, are also on hand for the Q&A portion of the call following our prepared remarks.